These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6935764)

  • 1. Comparison at the clinical level of different types and routes of heparin administration.
    Bouvier CA
    Scand J Haematol Suppl; 1980; 36():91-100. PubMed ID: 6935764
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetics of heparin after a single intravenous or subcutaneous injection].
    Mombelli G; Schaedelin J; Beck EA
    Schweiz Med Wochenschr; 1977 Jun; 107(23):810-5. PubMed ID: 877532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma heparin levels after administration of calcium and sodium salts of heparin.
    Thomas DP; Sagar S; Stamatakis JD; Maffei FH; Erdi A; Kakkar VV
    Thromb Res; 1976 Sep; 9(3):241-8. PubMed ID: 790636
    [No Abstract]   [Full Text] [Related]  

  • 4. Micromethod for the determination of heparin in plasma after intravenous and subcutaneous administration.
    Oreste P; Peruzzi M; Stella P
    Anal Biochem; 1993 Apr; 210(1):136-9. PubMed ID: 8489009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of various methods of heparin treatment].
    Chojnowski K; Judkiewicz L; Ciszewski R; Majda J
    Pol Tyg Lek; 1985 Nov; 40(44):1232-4. PubMed ID: 3911186
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative plasma heparin levels after subcutaneous administration of calcium and magnesium heparin.
    Follea G; Trzeciak MC; Dechavanne M
    Thromb Res; 1981 Jul 1-15; 23(1-2):33-9. PubMed ID: 7302920
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative plasma heparin levels after subcutaneous sodium and calcium heparin.
    Low J; Biggs JC
    Thromb Haemost; 1978 Oct; 40(2):397-406. PubMed ID: 734636
    [No Abstract]   [Full Text] [Related]  

  • 8. Delayed-type hypersensitivity to heparin with tolerance of its intravenous administration.
    Irion R; Gall H; Peter RU
    Contact Dermatitis; 2000 Oct; 43(4):249-50. PubMed ID: 11011948
    [No Abstract]   [Full Text] [Related]  

  • 9. An objective study of alternative methods of heparin administration.
    Bentley PG; Kakkar VV; Scully MF; MacGregor IR; Webb P; Chan P; Jones N
    Thromb Res; 1980 Apr 1-15; 18(1-2):177-87. PubMed ID: 7404497
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intravenous or subcutaneous heparin. What is better in deep venous thrombosis?].
    MMW Fortschr Med; 2002 Jun; 144(26):55. PubMed ID: 12154485
    [No Abstract]   [Full Text] [Related]  

  • 11. Heparin therapy.
    Osborne MP
    N Engl J Med; 1968 Oct; 279(16):888-9. PubMed ID: 5677730
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetics in normal humans of anticoagulant activity, radioactivity and lipolytic activity after intravenous administration of (S35) heparin and (S35) heparin fractions.
    De Swart CA; Sixma JJ; Andersson LO; Holmer E; Verschoor L; Nijmeyer A
    Scand J Haematol Suppl; 1980; 36():50-63. PubMed ID: 6935761
    [No Abstract]   [Full Text] [Related]  

  • 13. Thromboelastographic evaluation of the method of heparin administration.
    Rosato FE; Rosato EF; Roberts B; Kinsley RF
    Am J Surg; 1967 Jun; 113(6):750-3. PubMed ID: 6023909
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of tissue source, salt and molecular weight and heparin activity.
    Thomas DP; Barrowcliffe TW; Johnson EA
    Scand J Haematol Suppl; 1980; 36():40-9. PubMed ID: 7006054
    [No Abstract]   [Full Text] [Related]  

  • 15. Delayed-type hypersensitivity to subcutaneous heparin with tolerance of i.v. administration.
    Liew G; Campbell C; Thursby P
    ANZ J Surg; 2004 Nov; 74(11):1020-1. PubMed ID: 15550103
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous challenge with heparins in patients with delayed-type skin reactions after subcutaneous administration of the drug.
    Trautmann A; Bröcker EB; Klein CE
    Contact Dermatitis; 1998 Jul; 39(1):43-4. PubMed ID: 9686990
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.
    Hull R; Delmore T; Carter C; Hirsh J; Genton E; Gent M; Turpie G; McLaughlin D
    N Engl J Med; 1982 Jan; 306(4):189-94. PubMed ID: 7033782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin.
    N Engl J Med; 1968 Aug; 279(6):320-1. PubMed ID: 5660305
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetics of heparin administration.
    Perry MO; Horton J
    Arch Surg; 1976 Apr; 111(4):403-9. PubMed ID: 1259578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The heparin-mobilisable pool of platelet factor 4: a comparison of intravenous and subcutaneous heparin and Kabi heparin fragment 2165.
    O'Brien JR; Etherington MD; Pashley MA
    Thromb Haemost; 1985 Dec; 54(4):735-8. PubMed ID: 4089807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.